Ionically Crosslinked Chitosan Nanoparticles as Gene Delivery Systems: Effect of PEGylation Degree on In Vitro and In Vivo Gene Transfer
Abstract:The purpose of this work was to develop a new type of nanoparticles made of PEG-grafted chitosans (CS-g-PEG) using tripolyphosphate (TPP) as a polyanionic crosslinker and to investigate the potential of these nanostructures as gene carriers. The formation of these nanoparticles was optimised by the evaluation of the combined effects of pH, PEGylation degree and chitosan/crosslinker ratio on the particle formation. The selected CS-g-PEG/TPP nanoparticles were studied with regard to their physico-chemical properties, DNA association efficiency as well as to their toxicity and gene expression in vitro. Furthermore, the best performing nanoparticle prototypes were also evaluated for their potential for in vivo gene delivery. CS-g-PEG/TPP nanoparticles displayed a high DNA association efficiency combined with high stability and low cellular toxicity. The results of the in vitro transfection assays showed positive effects of the PEGylation in the case of particles prepared from high molecular weight chitosan, while the presence of PEG slightly decreased the efficiency of the nanoparticles based on low molecular weight chitosan. Overall, high and long lasting gene expression levels could be observed for all types of nanoparticles. Moreover, CS-g-PEG/TPP nanoparticles also mediated high gene expression levels in vivo, following nasal administration. These results indicate the potential of ionically crosslinked CS-g-PEG/TPP nanoparticles as transmucosal gene delivery systems.
Document Type: Research Article
Publication date: 2009-04-01
More about this publication?
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites